UPB vs VALN

Upstream Bio, Inc. vs Valneva SE — Valuation Comparison 2026

UPB

Biotechnology
Upstream Bio, Inc.
Quality
5.9
out of 10
Value Trap
12
SAFE
Price
$8.32
Last close
Models
9/13
Active
VS

VALN

Biotechnology
Valneva SE
Quality
5.3
out of 10
Value Trap
26
LOW
Price
$6.30
Last close
Models
11/13
Active

Model-by-Model Comparison

ModelType UPB Fair ValueUPB Upside VALN Fair ValueVALN Upside
Bayesian DCF Intrinsic $3.18 -61.8% $1.34 -78.8%
Earnings Power Value Intrinsic $2.37 -55.7%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $5.79 -30.4% $0.25 -96.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for UPB vs VALN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

UPB vs VALN — Which Stock Is More Undervalued?

UPB scores higher with a 5.9/10 quality rating vs VALN's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Upstream Bio, Inc. (UPB) and Valneva SE (VALN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

UPB currently trades at $8.32 with a QOC of 5.9/10, while VALN trades at $6.30 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).